This company develops Molecular Breast Imaging (MBI) technology to enhance cancer detection, particularly in dense breast tissue where mammography sensitivity is reduced. The MBI system uses a cancer tracer and gamma cameras to provide functional imaging that highlights areas of high cellular activity. This approach offers increased certainty and clarity in identifying early-stage cancers with a more comfortable patient experience than traditional screening methods.
Funding
$12.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional mammography often fails to detect early-stage breast cancer in women with dense breast tissue, identifying only 30% of cancers present. This limitation can lead to delayed diagnoses and poorer treatment outcomes for women with dense breasts. Mammography can also be painful and uncomfortable for patients.
Solution
SmartBreast offers Molecular Breast Imaging (MBI) with its Eve Clear Scan technology, a non-invasive method for early breast cancer detection, particularly in women with dense breast tissue. MBI uses an injected cancer tracer and gamma cameras to identify areas of increased cellular activity, indicative of cancer, even before anatomical changes are visible via mammography or MRI. The ergonomic design of the MBI system minimizes breast compression, offering a more comfortable experience compared to traditional mammograms. MBI finds 3-4x more early-stage cancers compared to mammography and results in fewer false positives.
Target Audience
The primary target audience includes women with dense breast tissue, as well as radiologists and healthcare providers seeking advanced breast cancer screening and diagnostic tools.
Features
- Molecular Breast Imaging (MBI) technology utilizing an injected cancer tracer and gamma cameras
- Functional imaging detects rapidly growing cancer cells based on differences in cellular activity
- Ergonomic design with minimal breast compression for patient comfort
- Increased cancer detection rate in dense breasts compared to mammography
- Fewer false positives, reducing the need for unnecessary biopsies
- Distinctive images even in dense breasts, detecting cancers often missed by mammography or MRI